To functionally confirm the tumor antigen specificity of predicted-reactive KIR+CD8+ T cells, we performed an unbiased epitope screen in 12 patients with melanoma for whom we have previously performed paired single-cell RNA and T cell receptor sequencing (Fig. 4A, table S1)7. This evidence concerns the gene KIR3DL1 and melanoma.